Shanghai-Hong Kong Zhongke
Biopharmaceutical preclinical research and development service company
Company News
Company News
2022-11-28
Preclinical CRO Company ZSHK Announces Completion of Nearly ¥100 Million Series B FinancingOn 28th November 2022 , ZSHK Laboratories Limited (ZSHK) announces its completion of nearly ¥100 million series B financing. Such series of financing was led by AZ-CICC Healthcare Fund and followed by existing shareholdersAscendum Capital....
Read more +2022-11-11
ZSHK was Invited to the Second Asia Summit on Global HealthOn 10 th November 2022. Hong Kong China. The second Asia Summit on Global Health (ASGH) was staged grandly at theHong Kong Convention and Exhibition Centre by the Hong Kong Government and Hong Kong Trade Development Council. The summit was t...
Read more +2022-11-08
ZSHK Debuts in 2022 ShenZhen International Biotech & Health Industry Expo and BT SummitIn 3 rd to 4 th November 2022, ShenZhen, China, ZSHK Laboratories Limited (ZSHK) and its wholly-owned subsidiariesAnling Biomed (Shenzhen) Co. ,Ltd. (Anling (Shenzhen)) and Anling Biomed (Suzhou) Co. ,Ltd. (Anling (Suzhou)) were invited to 2...
Read more +2022-10-17
AnLing (ShenZhen) is Granted Full Accreditation from AAALACOctober 14, 2022. AnLing Biomedical (ShenZhen) Co., Ltd (hereinafter referred to as AnLing (ShenZhen)) has successfully been awarded FULL ACCREDITATION from the Association for Assessment and Accreditation of Laboratory Animal Care Internati...
Read more +2022-07-15
Director of Standing Committee of the People's Congress of Shenzhen Municipality Visits AnLing Bio (ShenZhen)On 11th July 2022 afternoon, Mr. Luo Wen Zhi, Director of Standing Committee of the Peoples Congress (SCPC) of Shenzhen Municipality and Mr Jiang Yu Yang, Vice Director of SCPC and President of Association of Science and Technology visits An...
Read more +